|
ACN9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.53480006481743E-10 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
5.878400E-01 |
| Stage1-vs-Stage3 |
1.419610E-01 |
| Stage1-vs-Stage4 |
4.384300E-02 |
| Stage2-vs-Stage3 |
7.223400E-01 |
| Stage2-vs-Stage4 |
7.330400E-01 |
| Stage3-vs-Stage4 |
9.696400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.96376248595698E-12 |
| Normal-vs-Asian |
7.532400E-01 |
| Caucasian-vs-AfricanAmerican |
6.824200E-02 |
| Caucasian-vs-Asian |
3.901800E-01 |
| AfricanAmerican-vs-Asian |
4.965000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.900100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63091762317435E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.11022302462516E-16 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.872400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.705000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.388430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.677400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.229800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.315410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.36309868842477E-11 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
6.028800E-01 |
| Grade 1-vs-Grade 3 |
7.427600E-01 |
| Grade 1-vs-Grade 4 |
3.787400E-01 |
| Grade 2-vs-Grade 3 |
6.645400E-01 |
| Grade 2-vs-Grade 4 |
1.022210E-02 |
| Grade 3-vs-Grade 4 |
1.196330E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
9.049200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.63069557856943E-12 |
| N0-vs-N1 |
1.216570E-01 |
|
|
